Leonard Osser - Milestone Scientific CEO and Director
| MLSS Stock | USD 0.94 0.02 2.08% |
CEO
Mr. Leonard A. Osser serves as Interim Chief Executive Officer, Director of the Company. He was Chief Executive Officer, Director of Milestone Scientific Inc. Prior to that, he served as Milestones Chairman from 1991 until September of 2009, and during that time, from 1991 until 2007, was also Chief Executive Officer of Milestone. In September 2009, he resigned as Chairman of Milestone, but remained a director, and assumed the position of Chief Executive Officer. From 1980 until the consummation of Milestones public offering in November 1995, Mr. Osser was primarily engaged as the principal owner and Chief Executive Officer of U.S. Asian Consulting Group, Inc., a New Jerseybased provider of consulting services specializing in distressed or turnaround situations in both the public and private markets since 2017.
| Age | 78 |
| Tenure | 8 years |
| Address | 425 Eagle Rock Avenue, Roseland, NJ, United States, 07068 |
| Phone | 973 535 2717 |
| Web | https://www.milestonescientific.com |
Leonard Osser Latest Insider Activity
Tracking and analyzing the buying and selling activities of Leonard Osser against Milestone Scientific stock is an integral part of due diligence when investing in Milestone Scientific. Leonard Osser insider activity provides valuable insight into whether Milestone Scientific is net buyers or sellers over its current business cycle. Note, Milestone Scientific insiders must abide by specific rules, including filing SEC forms every time they buy or sell Milestone Scientific'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Leonard Osser over a month ago Disposition of 7110 shares by Leonard Osser of Milestone Scientific at 1.33 subject to Rule 16b-3 |
Milestone Scientific Management Efficiency
The company has return on total asset (ROA) of (0.3846) % which means that it has lost $0.3846 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6521) %, meaning that it created substantial loss on money invested by shareholders. Milestone Scientific's management efficiency ratios could be used to measure how well Milestone Scientific manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.59 in 2025. Return On Capital Employed is likely to drop to -0.81 in 2025. At this time, Milestone Scientific's Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 19.4 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 493.4 K in 2025.Similar Executives
| Found 5 records | CEO Age | ||
| Richard Diiorio | InfuSystems Holdings | 50 | |
| Michael Stewart | STRATA Skin Sciences | 68 | |
| Ronald Andrews | OncoCyte Corp | 64 | |
| Michael West | OncoCyte Corp | 72 | |
| Dolev Rafaeli | STRATA Skin Sciences | 61 | |
Management Performance
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.38 |
Milestone Scientific Leadership Team
Elected by the shareholders, the Milestone Scientific's board of directors comprises two types of representatives: Milestone Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Milestone. The board's role is to monitor Milestone Scientific's management team and ensure that shareholders' interests are well served. Milestone Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Milestone Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James JD, Senior Development | ||
| Jan Haverhals, President Director | ||
| James McAvinn, Senior Vice President - Sales & Marketing | ||
| Leonard Osser, CEO and Director | ||
| Andy Molnar, Senior Dental | ||
| Keisha Harcum, Controller | ||
| Neal CFA, Chairman CEO |
Milestone Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Milestone Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.38 | ||||
| Profit Margin | (0.52) % | ||||
| Operating Margin | (0.58) % | ||||
| Current Valuation | 68.5 M | ||||
| Shares Outstanding | 77.89 M | ||||
| Shares Owned By Insiders | 22.91 % | ||||
| Shares Owned By Institutions | 5.69 % | ||||
| Number Of Shares Shorted | 116.76 K | ||||
| Price To Earning | (6.39) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.